Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Onyia Jude sold 11,000 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Onyia Jude (Chief Scientific Officer) sold 11,000 Neurocrine Biosciences, Inc. shares at US$160.25 for US$1.76M under a trading plan, leaving 25,846 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 11,000 shares
- Price
- US$160.25
- Value
- US$1.76M
- Holding after
- 25,846 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 11,000 | US$84.74 | 36,846 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 11,000 | US$160.25 | 25,846 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Onyia Jude
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Onyia Jude · Sep 15, 2026
- Form 4 · Onyia Jude · Aug 5, 2026
- Form 4 · Onyia Jude · Jun 9, 2026
- Form 4 · Onyia Jude · May 29, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Lippoldt Darin · Sep 15, 2026